Schedule 13G ownership disclosure

APPLIED THERAPEUTICS INC

Common Stock, par value $0.0001 per share · CUSIP: 03828A101

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Vestal Point Capital, LP

    Shares: 11,500,000.00 · Class: 9.9%

  • Ryan Wilder

    Shares: 11,500,000.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-001007
Form type
SCHEDULE 13G
Filer
Applied Therapeutics, Inc.
CIK
CIK 1697532
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub